Kaynak S, Tekin N F, Durak I, Berk A T, Saatci A O, Soylev M F
Department of Ophthalmology, Dokuz Eylül University, Izmir, Turkey.
Br J Ophthalmol. 1998 Dec;82(12):1377-82. doi: 10.1136/bjo.82.12.1377.
Intractable glaucoma is glaucoma resistant to medical therapy and conventional surgical procedures. In this study, a planned surgical technique is discussed for controlling the increased intraocular pressure in selected cases with intractable glaucoma.
Total pars plana vitrectomy with pars plana tube implantation was performed in 17 eyes of 17 cases with intractable glaucoma. Patients with neovascular glaucoma were not included in this study. The mean age of these patients (seven men, 10 women) was 44.6 (SD 22.1) years and mean follow up period was 30.3 (15.5) months (range 4-71). Drainage implants with a disc were used in 16 cases, whereas, a tube with scleral buckle (Schocket surgery) was preferred in one case. An intraocular pressure below or equal to 20 mm Hg without any adjunctive medication or with only one type of antiglaucomatous drop was considered as an adequate operative outcome.
16 out of 17 eyes maintained adequate pressure control. Only three out of these 16 eyes required prophylactic antiglaucomatous medications. One patient underwent reoperation for pressure control. The most severe complications observed postoperatively were intravitreal haemorrhage (one case), choroidal detachment (one case), implant failure (one case), total retinal detachment (two cases), and corneal endothelial decompensation (five cases).
Pars plana placement of drainage tube following pars plana vitrectomy should be considered as an alternative method for controlling increased intraocular pressures in selected patients with intractable glaucoma.
难治性青光眼是指对药物治疗和传统手术方法均有抵抗的青光眼。本研究讨论一种计划性手术技术,用于控制部分难治性青光眼病例中升高的眼压。
对17例难治性青光眼患者的17只眼进行了经睫状体平坦部玻璃体切除术并植入睫状体平坦部引流管。新生血管性青光眼患者未纳入本研究。这些患者(7名男性,10名女性)的平均年龄为44.6(标准差22.1)岁,平均随访期为30.3(15.5)个月(范围4 - 71个月)。16例使用带盘的引流植入物,而1例则首选带巩膜扣带的引流管(肖克特手术)。眼压低于或等于20 mmHg,且无需任何辅助药物或仅使用一种抗青光眼滴眼液,被视为手术效果良好。
17只眼中有16只眼眼压得到了充分控制。在这16只眼中,只有3只眼需要预防性抗青光眼药物治疗。1例患者因眼压控制不佳接受了再次手术。术后观察到的最严重并发症为玻璃体内出血(1例)、脉络膜脱离(1例)、植入物失败(1例)、视网膜全脱离(2例)和角膜内皮失代偿(5例)。
经睫状体平坦部玻璃体切除术后在睫状体平坦部放置引流管应被视为控制部分难治性青光眼患者眼压升高的一种替代方法。